Y Intercept (Hong Kong) LTD Organon & Co. Transaction History

Y Intercept (Hong Kong) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.78 - $18.8 $523,433 - $714,118	37,985 New	37,985 $714,000
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $429,664 - $615,619	25,899 New	25,899 $449,000
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $315,547 - $387,293	13,537 New	13,537 $378,000
Q2 2022 Aug 08, 2022	SELL	$31.66 - $38.9 $185,305 - $227,681	-5,853 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$30.45 - $39.36 $178,223 - $230,374	5,853 New	5,853 $204,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.